308 related articles for article (PubMed ID: 28230645)
1. Clinical-Scale Rapid Autologous BK Virus-Specific T Cell Line Generation From Kidney Transplant Recipients With Active Viremia for Adoptive Immunotherapy.
Lamarche C; Orio J; Georges-Tobar V; Pincez T; Goupil M; Dahmani A; Carli C; Brasey A; Busque L; Delisle JS
Transplantation; 2017 Nov; 101(11):2713-2721. PubMed ID: 28230645
[TBL] [Abstract][Full Text] [Related]
2. Antigenic competition in the generation of multi-virus-specific cell lines for immunotherapy of human cytomegalovirus, polyomavirus BK, Epstein-Barr virus and adenovirus infection in haematopoietic stem cell transplant recipients.
Roubalová K; Němečková Š; Kryštofová J; Hainz P; Pumannová M; Hamšíková E
Immunol Lett; 2020 Dec; 228():64-69. PubMed ID: 33031870
[TBL] [Abstract][Full Text] [Related]
3. BK Polyomavirus-specific T Cells as a Diagnostic and Prognostic Marker for BK Polyomavirus Infections After Pediatric Kidney Transplantation.
Ahlenstiel-Grunow T; Sester M; Sester U; Hirsch HH; Pape L
Transplantation; 2020 Nov; 104(11):2393-2402. PubMed ID: 31985731
[TBL] [Abstract][Full Text] [Related]
4. Antigen-specific T cell responses to BK polyomavirus antigens identify functional anti-viral immunity and may help to guide immunosuppression following renal transplantation.
Chakera A; Bennett S; Lawrence S; Morteau O; Mason PD; O'Callaghan CA; Cornall RJ
Clin Exp Immunol; 2011 Sep; 165(3):401-9. PubMed ID: 21671906
[TBL] [Abstract][Full Text] [Related]
5. BK virus nephropathy in renal transplant recipients.
Jamboti JS
Nephrology (Carlton); 2016 Aug; 21(8):647-54. PubMed ID: 26780694
[TBL] [Abstract][Full Text] [Related]
6. Update on the Management of BK Virus Infection.
Saleh A; El Din Khedr MS; Ezzat A; Takou A; Halawa A
Exp Clin Transplant; 2020 Nov; 18(6):659-670. PubMed ID: 32552624
[TBL] [Abstract][Full Text] [Related]
7. Diagnostics, treatment, and immune response in BK polyomavirus infection after pediatric kidney transplantation.
Ahlenstiel-Grunow T; Pape L
Pediatr Nephrol; 2020 Mar; 35(3):375-382. PubMed ID: 30539254
[TBL] [Abstract][Full Text] [Related]
8. BK Virus in Kidney Transplant: Current Concepts, Recent Advances, and Future Directions.
Sharma R; Tzetzo S; Patel S; Zachariah M; Sharma S; Melendy T
Exp Clin Transplant; 2016 Aug; 14(4):377-84. PubMed ID: 27267780
[TBL] [Abstract][Full Text] [Related]
9. Increased Frequency of BK Virus-Specific Polyfunctional CD8+ T Cells Predict Successful Control of BK Viremia After Kidney Transplantation.
Schaenman JM; Korin Y; Sidwell T; Kandarian F; Harre N; Gjertson D; Lum EL; Reddy U; Huang E; Pham PT; Bunnapradist S; Danovitch GM; Veale J; Gritsch HA; Reed EF
Transplantation; 2017 Jun; 101(6):1479-1487. PubMed ID: 27391197
[TBL] [Abstract][Full Text] [Related]
10. BK Polyomavirus Immune Response With Stress on BK-Specific T Cells.
El Hennawy HM
Exp Clin Transplant; 2018 Aug; 16(4):376-385. PubMed ID: 29766776
[TBL] [Abstract][Full Text] [Related]
11. Correlation of BK Virus Neutralizing Serostatus With the Incidence of BK Viremia in Kidney Transplant Recipients.
Abend JR; Changala M; Sathe A; Casey F; Kistler A; Chandran S; Howard A; Wojciechowski D
Transplantation; 2017 Jun; 101(6):1495-1505. PubMed ID: 27854236
[TBL] [Abstract][Full Text] [Related]
12. Cellular immunotherapy for patients with reactivation of JC and BK polyomaviruses after transplantation.
Mani J; Jin N; Schmitt M
Cytotherapy; 2014 Oct; 16(10):1325-35. PubMed ID: 24934303
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of Intravenous Immunoglobulin in the Treatment of Persistent BK Viremia and BK Virus Nephropathy in Renal Transplant Recipients.
Shah T; Vu D; Naraghi R; Campbell A; Min D
Clin Transpl; 2014; ():109-16. PubMed ID: 26281134
[TBL] [Abstract][Full Text] [Related]
14. BK Virus in Renal Transplant Patients Using Alemtuzumab for Induction Immunosuppression.
Korneffel K; Gehring B; Rospert D; Rees M; Ortiz J
Exp Clin Transplant; 2020 Oct; 18(5):557-563. PubMed ID: 31324134
[TBL] [Abstract][Full Text] [Related]
15. Long-Term Follow-Up of Active Treatment Versus Minimization of Immunosuppressive Agents in Patients With BK Virus-Associated Nephropathy After Kidney Transplant.
Halim MA; Al-Otaibi T; Gheith O; Mosaad A; Zakaria Z; Said T; Nair P; Nampoory NM
Exp Clin Transplant; 2016 Feb; 14(1):58-65. PubMed ID: 26862825
[TBL] [Abstract][Full Text] [Related]
16. Screening for BK Viremia/Viruria and the Impact of Management of BK Virus Nephropathy in Renal Transplant Recipients.
Zakaria ZE; Elokely AM; Ghorab AA; Bakr AI; Halim MA; Gheith OA; Nagib AM; Makkeyah Y; Balaha MA; Magdy MM; Al-Otaibi T
Exp Clin Transplant; 2019 Jan; 17(Suppl 1):83-91. PubMed ID: 30777529
[TBL] [Abstract][Full Text] [Related]
17. Different behaviour of BK-virus infection in liver transplant recipients.
Umbro I; Tinti F; Muiesan P; Mitterhofer AP
World J Gastroenterol; 2016 Jan; 22(4):1532-40. PubMed ID: 26819520
[TBL] [Abstract][Full Text] [Related]
18. Dendritic cell deficiency associated with development of BK viremia and nephropathy in renal transplant recipients.
Womer KL; Huang Y; Herren H; Dibadj K; Peng R; Murawski M; Shraybman R; Patton P; Clare-Salzler MJ; Kaplan B
Transplantation; 2010 Jan; 89(1):115-23. PubMed ID: 20061927
[TBL] [Abstract][Full Text] [Related]
19. Viral infections directly involved in kidney allograft function.
Masutani K
Nephrology (Carlton); 2018 Jul; 23 Suppl 2():31-37. PubMed ID: 29968408
[TBL] [Abstract][Full Text] [Related]
20. Conversion From Mycophenolates to Mizoribine Is Associated With Lower BK Virus Load in Kidney Transplant Recipients: A Prospective Study.
Yuan X; Chen C; Zheng Y; Wang C
Transplant Proc; 2018 Dec; 50(10):3356-3360. PubMed ID: 30577207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
